Literature DB >> 34424271

Response to Nahshon and Lavie.

Cornelis D de Kroon1, Marthe M de Jonge2, Tjalling Bosse2, Christi J van Asperen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34424271      PMCID： PMC8826548          DOI： 10.1093/jnci/djab155

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   11.816


× No keyword cloud information.
  5 in total

Review 1.  Total Laparoscopic Hysterectomy Versus Vaginal Hysterectomy: A Systematic Review and Meta-Analysis.

Authors:  Evelien M Sandberg; Andries R H Twijnstra; Sara R C Driessen; Frank Willem Jansen
Journal:  J Minim Invasive Gynecol       Date:  2016-11-17       Impact factor: 4.137

2.  BRCA1/2 and Endometrial Cancer Risk: Implications for Management.

Authors:  Mark E Sherman; William D Foulkes
Journal:  J Natl Cancer Inst       Date:  2021-09-04       Impact factor: 13.506

3.  Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.

Authors:  Michael E Jones; Flora E van Leeuwen; Wilhelmina E Hoogendoorn; Marian Je Mourits; Harry Hollema; Hester van Boven; Michael F Press; Leslie Bernstein; Anthony J Swerdlow
Journal:  Breast Cancer Res       Date:  2012-06-12       Impact factor: 6.466

4.  RE: Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

Authors:  Chen Nahshon; Ofer Lavie
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 11.816

5.  Risk of Endometrial Cancer and Frequencies of Invasive Endometrial Procedures in Young Breast Cancer Survivors Treated With Tamoxifen: A Nationwide Study.

Authors:  Soojeong Choi; Young Jae Lee; Jae Ho Jeong; Jinhong Jung; Jong Won Lee; Hee Jeong Kim; Beom Seok Ko; Byung Ho Son; Sei Hyun Ahn; Yura Lee; Il Yong Chung
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.